US Patent 10383928 Telomerase polypeptide vaccine for treating cancer
Patent 10383928 was granted and assigned to Ultimovacs on August, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 27, 2017
Date of Patent
August 20, 2019
Patent Applicant
Patent Application Number
15498733
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10383928 Telomerase polypeptide vaccine for treating cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
